Al­ny­lam files a new set of law­suits against Mod­er­na and Pfiz­er over Covid-19 vac­cines

Al­ny­lam has once again ac­cused Pfiz­er and Mod­er­na of in­fring­ing patents around its lipid nanopar­ti­cle tech­nol­o­gy.

In two law­suits filed Fri­day, Al­ny­lam al­leged that Pfiz­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER